255 related articles for article (PubMed ID: 7963691)
1. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis.
Yuspa SH; Długosz AA; Cheng CK; Denning MF; Tennenbaum T; Glick AB; Weinberg WC
J Invest Dermatol; 1994 Nov; 103(5 Suppl):90S-95S. PubMed ID: 7963691
[TBL] [Abstract][Full Text] [Related]
2. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
[TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Glick AB; Lee MM; Darwiche N; Kulkarni AB; Karlsson S; Yuspa SH
Genes Dev; 1994 Oct; 8(20):2429-40. PubMed ID: 7958907
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
6. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
7. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
8. Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha.
Dlugosz AA; Cheng C; Williams EK; Dharia AG; Denning MF; Yuspa SH
Cancer Res; 1994 Dec; 54(24):6413-20. PubMed ID: 7987836
[TBL] [Abstract][Full Text] [Related]
9. Multistage carcinogenesis in the skin.
Yuspa SH; Dlugosz AA; Denning MF; Glick AB
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):147-50. PubMed ID: 9627709
[TBL] [Abstract][Full Text] [Related]
10. Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta.
Denning MF; Dlugosz AA; Howett MK; Yuspa SH
J Biol Chem; 1993 Dec; 268(35):26079-81. PubMed ID: 8253722
[TBL] [Abstract][Full Text] [Related]
11. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
12. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.
Greenhalgh DA; Welty DJ; Player A; Yuspa SH
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):643-7. PubMed ID: 2153961
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous chemical carcinogenesis.
Yuspa SH
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1031-44. PubMed ID: 3537025
[TBL] [Abstract][Full Text] [Related]
14. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
15. Analysis of phospholipid metabolism in murine keratinocytes transformed by the v-ras oncogene: relationship of phosphatidylinositol turnover and cytokine stimulation to the transformed phenotype.
Lee E; Punnonen K; Cheng C; Glick A; Dlugosz A; Yuspa SH
Carcinogenesis; 1992 Dec; 13(12):2367-73. PubMed ID: 1473246
[TBL] [Abstract][Full Text] [Related]
16. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
17. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
18. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
19. Transfection of the EJ rasHa gene into keratinocytes derived from carcinogen-induced mouse papillomas causes malignant progression.
Harper JR; Roop DR; Yuspa SH
Mol Cell Biol; 1986 Sep; 6(9):3144-9. PubMed ID: 2431297
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis.
Yuspa SH
J Dermatol Sci; 1998 May; 17(1):1-7. PubMed ID: 9651822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
